Lung - Cancer

JANS Article

An STS General Thoracic Surgery Database Analysis of the Association Between LN Dissection and Chylothorax

September 24, 2026 | Akshay PatelSilver Contributor

This Society of Thoracic Surgeons General Thoracic Surgery Database analysis found that postoperative chylothorax risk increases with the extent of lymph-node dissection during pulmonary resection. Although uncommon, chylothorax was associated with substantial morbidity, including longer...

JANS Article

Right Basilar Segmental Autologous Lung Transplantation With Carinal Reconstruction for Central Lung SCC

September 24, 2026 | Akshay PatelSilver Contributor

This case report describes a 75-year-old patient with a centrally located squamous cell carcinoma extending from the carina to the right intermediate bronchus and the superior segment of the lower...

JANS Article

An STS General Thoracic Surgery Database Analysis of the Association Between LN Dissection and Chylothorax

September 24, 2026 | Akshay PatelSilver Contributor

This Society of Thoracic Surgeons General Thoracic Surgery Database analysis found that postoperative chylothorax risk increases with the extent of lymph-node dissection during pulmonary resection. Although uncommon, chylothorax was associated...

Podcast

The Beat With Joel Dunning Ep. 173: Uniportal Robotics in the UAE

September 10, 2026 | Joel DunningGold ContributorSilver Commentor

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the...

JANS Article

Tumor Mutational Burden as a Predictor of Immune-Related Adverse Events in Patients With Advanced Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Brief Report

September 3, 2026 | Akshay PatelSilver Contributor

High tumor mutational burden (TMB) predicts not only response to immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) but also immune-related toxicity. In this single-center cohort of...

JANS Article

Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer

June 5, 2025 | Jade QuSilver Contributor

This study evaluated the SHURUI single-port (SP) robotic system for uniportal robotic-assisted thoracic surgery (RATS) in lung cancer patients. Unlike conventional multi-incision systems, the SHURUI SP utilizes a single, highly...

JANS Article

Touching (Proximity) as a Companion Diagnostic Test

June 5, 2025 | Akshay PatelSilver Contributor

This article discusses a promising diagnostic approach aimed at improving patient selection for immune checkpoint inhibitor (ICI) therapies, particularly in non-small cell lung cancer (NSCLC). The current reliance on PD-L1...

JANS Article

Advancing the Needle on the Management of Resectable EGFR-Positive NSCLC: Is Neoadjuvant Osimertinib the Answer?

June 5, 2025 | Akshay PatelSilver Contributor

This article reviews recent efforts to evaluate the use of osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in the neoadjuvant setting for patients with resectable EGFR-mutant non-small cell lung...

JANS Article

Optimizing Surgical Precision: A Comparative Study of Three-Port vs. Four-Port Robotic-Assisted Lobectomy for NSCLC

May 7, 2025 | Jade QuSilver Contributor

This retrospective analysis compared three-port and four-port robotic-assisted thoracoscopic surgery (RATS) lobectomy for non-small cell lung cancer (NSCLC)(n=121, 2020–2021). Demographics, tumor characteristics, complications, and lymph node yields were similar between...

JANS Article

Extended Sleeve Lobectomy After Neoadjuvant Immunochemotherapy for Centrally Located Non-Small Cell Lung Cancer

May 1, 2025 | Jade QuSilver Contributor

Extended sleeve lobectomy (ESL) is considered a lung-sparing alternative to pneumonectomy (PN) for centrally located non-small cell lung cancer (NSCLC) when standard sleeve lobectomy (SSL) is not feasible. This retrospective...

JANS Article

Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)

May 1, 2025 | Jade QuSilver Contributor

The recent CheckMate 816 trial indicated that neoadjuvant chemo-immunotherapy provided limited local control in stage II–III resectable non-small cell lung cancer (NSCLC). This trial evaluated the hypothesis that incorporating radiotherapy...

JANS Article

Estimated Worldwide Variation and Trends in Incidence of Lung Cancer by Histological Subtype in 2022 and Over Time: A Population-Based Study

April 17, 2025 | Akshay PatelSilver Contributor

This article presents a comprehensive epidemiological analysis of lung cancer, focusing on subtype-specific patterns worldwide. Using data from GLOBOCAN 2022 and other international cancer registries, the study estimated more than...

JANS Article

Tumour Spread Through Air Spaces Is a Determiner for Treatment of Clinical Stage I Non-Small Cell Lung Cancer: Thoracoscopic Segmentectomy vs Lobectomy

March 13, 2025 | Akshay PatelSilver Contributor

This study investigates the impact of tumor spread through air spaces (STAS) on surgical outcomes for early-stage non-small cell lung cancer (NSCLC). In a retrospective analysis of 785 patients, 19.2...

LOAD MORE
ADVERTISE ON CTSNET